You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of a transgenic mouse line engineered to permit selection and cloning
SBC: ABEOME CORPORATION Topic: NCRRDESCRIPTION (provided by applicant): The Applicant proposes an improvement to monoclonal antibody technology through the generation of transgenic mice engineered to facilitate flow cytometric isolation and cloning of specific antigen-reactive plasmacytes. Monoclonal antibodies (mAbs) are arguably the most important biological reagents used in biomedical research, diagnostics, and therapeutics, and ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Personal Ozone Monitor
SBC: 2B TECHNOLOGIES, INC. Topic: NIEHSDESCRIPTION (provided by applicant): In this proposal we respond to the call by the National Institute of Environmental Health Sciences (NIEHS) in the PHS 2009-2 Omnibus Solicitation, Exposure Biology Program, Section 1, Technologies for Generating Precise Measures of Environmental Exposures for new products/devices, tools, assays to improve our ability to precisely measure environmental exposure ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
HealthCare Manager: A Remote Medication and Personal Health Plan Support System
SBC: ABLELINK TECHNOLOGIES INC Topic: NIADESCRIPTION (provided by applicant): As the well known baby boomer generation surges toward retirement age, the issue becomes more significant each day of how this generation of 78 million seniors will be able to remain as independent as possible while increasingly burdened by the onset of multiple, chronic, medical conditions and a decline in cognitive abilities. Concurrent with the dramatic incr ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
A Low-Cost Upper-Extremity Prosthetic Interface
SBC: ADA TECHNOLOGIES, INC. Topic: NICHDDESCRIPTION (provided by applicant): Remarkable advances in signal processing techniques, materials sciences, battery technologies, and computer-aided design and computer-aided manufacturing (CAD/CAM) processes have led to significant developments in assistive technologies. Coordinated research and commercialization have dramatically increased prosthetic function, utility, personalization, comfort ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Safe and Cost Effective Water Remediation, Enabled by an Online Perchlorate Analyze
SBC: ADVANCED MICROLABS, LLC Topic: NIEHSDESCRIPTION (provided by applicant): Perchlorate, ClO4-, is a small highly water soluble anion created by both geogenic and anthropogenic sources. Anthropogenic sources include solid rocket fuel, matches, dyes, paints, airbag inflators, pyrotechnics, flares, and fertilizers. Human exposure to perchlorate is of concern because of the potential for impaired thyroid function, leading to a number of d ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A novel DC-targeting non-integrating lentivector vaccine for HIV infection
SBC: TRIA BIOSCIENCE CORP. Topic: NIAIDDESCRIPTION (provided by applicant): Despite two decades of persistent research on prophylactic and therapeutic immunization against HIV, an effective vaccine-based solution to the HIV pandemic has remained elusive. However, the last few years have provided important insights into the type of immune response that would be required for an effective HIV vaccine. For instance, in studies of natural H ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Simultaneous Stimulation and Recording in Scalable Microelectrode Arrays
SBC: Axion Biosystems, Inc. Topic: NINDSDESCRIPTION (provided by applicant): The proposed study utilizes novel electronics and microfabrication techniques to create scalable, in-vitro Microelectrode Array (MEA) technologies that conform to industry standards for multiwell plates. This research will not only enable rapid advancements in the study of network-level electrophysiology, but it will also create new opportunities for pharmaceut ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Online PCT Training for Clinicians
SBC: BEHAVIORAL TECH RESEARCH, INC. Topic: NIMHDESCRIPTION (provided by applicant): Panic attacks (PA) impact about 23% of adults in community samples. Panic disorder with or without agoraphobia (PDA) tends to be a chronic condition with a lifetime prevalence of 4.7%. When untreated, panic disorder (PD) often leads to debilitating problems, with severe financial and interpersonal costs. Panic Control Treatment (PCT) is an efficacious treatment ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Multi-Line Refreshable Braille Display
SBC: TACTILE DISPLAY CORPORATION Topic: NEIDESCRIPTION (provided by applicant): The project proposed by Tactile Display Corporation (TDC) supports the NIH/NEI mission to develop devices to aid the blind. A blind student has 2 hurdles to overcome when reading with today's refreshable braille display (RBD): the inability to read more than one line at a time because these devices only display a single line of text, and, the inability to read ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting IL-11 Analog for Treating Acute Radiation Syndrome
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting in death. Interleukin-11 (IL-11) is a ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health